NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Essential hypertension
Date of first enrollment	29/07/2005
Target sample size
Countries of recruitment
Study type	Observational
Intervention(s)	investigational material(s) Generic name etc : Olmetec(Olmesartan Medoxomil) INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Development of stroke,myocardial infarction, unstable angina required hospitalization,and sudden and unexpected death.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 50age old
Age maximum	<= 79age old
Gender	Both
Include criteria	Essential hypertension, outpatient, consenting patient, age 50-79.
Exclude criteria	A history of myocardial infarction, stroke, coronary artery bypass graft surgery, and percutaneous coronary intervention within 6 months before the registration.A scheduled coronary intervention at registration. A diagnosis congenital or rheumatic heart disease, severe arrhythmia, liver or renal disease, and current diagnosis of malignancy.